Functional analysis of dopaminergic systems in a DYT1 knock-in mouse model of dystonia

scientific article

Functional analysis of dopaminergic systems in a DYT1 knock-in mouse model of dystonia is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.NBD.2012.05.009
P932PMC publication ID3498628
P698PubMed publication ID22659308

P2093author name stringH A Jinnah
Ellen J Hess
Xueliang Fan
Chang-Hyun Song
Cicely J Exeter
P2860cites workThe basal ganglia and cerebellum interact in the expression of dystonic movementQ24653882
Dopamine deficiency in a genetic mouse model of Lesch-Nyhan diseaseQ28510609
Immunocytochemical characterization of torsin proteins in mouse brainQ28511582
Loss of the dystonia-associated protein torsinA selectively disrupts the neuronal nuclear envelopeQ28589351
Amphetamine-induced behavioral phenotype in a hypoxanthine-guanine phosphoribosyltransferase-deficient mouse model of Lesch-Nyhan syndromeQ28589709
Functional analysis of brain dopamine systems in a genetic mouse model of Lesch-Nyhan syndromeQ28591144
Rodent models for dystonia research: characteristics, evaluation, and utilityQ33210715
Abnormal structure-function relationships in hereditary dystoniaQ33402008
Cell-autonomous alteration of dopaminergic transmission by wild type and mutant (DeltaE) TorsinA in transgenic mice.Q33723034
Altered dendritic morphology of Purkinje cells in Dyt1 ΔGAG knock-in and purkinje cell-specific Dyt1 conditional knockout mice.Q33867544
Immunohistochemical localization and distribution of torsinA in normal human and rat brainQ33886989
Cellular distribution of torsin A and torsin B in normal human brainQ33951281
Motor deficits and decreased striatal dopamine receptor 2 binding activity in the striatum-specific Dyt1 conditional knockout miceQ34023627
Oxidative stress and dopamine deficiency in a genetic mouse model of Lesch-Nyhan diseaseQ34117291
Expression of the early-onset torsion dystonia gene (DYT1) in human brain.Q34467898
Dystonia in Parkinson's diseaseQ34585274
Cerebellothalamocortical pathway abnormalities in torsinA DYT1 knock-in mice.Q34836384
Commentary: Dopaminergic dysfunction in DYT1 dystoniaQ35009095
The DYT1 carrier state increases energy demand in the olivocerebellar networkQ35210345
Dysfunction of dopaminergic pathways in dystoniaQ35543720
An anticholinergic reverses motor control and corticostriatal LTD deficits in Dyt1 ΔGAG knock-in miceQ35576523
Motor deficits and hyperactivity in Dyt1 knockdown mice.Q35629540
D2-like dopamine receptors mediate the response to amphetamine in a mouse model of ADHD.Q35809256
Improved motor performance in Dyt1 ΔGAG heterozygous knock-in mice by cerebellar Purkinje-cell specific Dyt1 conditional knocking-outQ35878028
Basal ganglia dopamine loss due to defect in purine recyclingQ35908559
The functional neuroanatomy of dystoniaQ36340491
Abnormal motor function and dopamine neurotransmission in DYT1 DeltaGAG transgenic miceQ36666604
TorsinA and dystonia: from nuclear envelope to synapse.Q37490209
Primary dystonia: molecules and mechanisms.Q37614200
Concept and classification of dystoniaQ39512463
Functional and molecular differentiation of the dopamine system induced by neonatal denervationQ41176113
Distribution of the mRNAs encoding torsinA and torsinB in the normal adult human brainQ42479695
Dopamine release is impaired in a mouse model of DYT1 dystoniaQ42513622
Impairment of bidirectional synaptic plasticity in the striatum of a mouse model of DYT1 dystonia: role of endogenous acetylcholine.Q42590497
Function of dopamine transporter is compromised in DYT1 transgenic animal model in vivoQ42593925
Impaired motor learning in mice expressing torsinA with the DYT1 dystonia mutation.Q42658331
Generation and characterization of Dyt1 DeltaGAG knock-in mouse as a model for early-onset dystoniaQ42671584
Behavioural and pharmacological examinations in a transgenic mouse model of early-onset torsion dystoniaQ42813363
The midbrain dopaminergic system: anatomy and genetic variation in dopamine neuron number of inbred mouse strainsQ43723860
The quantiative measurement of motor inco-ordination in naive mice using an acelerating rotarodQ44169382
Dopamine transmission in DYT1 dystoniaQ44596265
Aberrant cellular behavior of mutant torsinA implicates nuclear envelope dysfunction in DYT1 dystonia.Q44804036
Ethanol's effects on gait dynamics in mice investigated by ventral plane videographyQ45193992
Transgenic mouse model of early-onset DYT1 dystoniaQ46232270
The metabolic pathology of dopa-responsive dystoniaQ46399764
Silencing primary dystonia: lentiviral-mediated RNA interference therapy for DYT1 dystonia.Q46798860
Motor deficits and hyperactivity in cerebral cortex-specific Dyt1 conditional knockout miceQ46935059
Age-dependent neurobehavioral plasticity following forebrain dopamine depletionsQ47738132
Overexpression of human wildtype torsinA and human DeltaGAG torsinA in a transgenic mouse model causes phenotypic abnormalities.Q48120915
TorsinA protein and neuropathology in early onset generalized dystonia with GAG deletionQ48378126
Altered responses to dopaminergic D2 receptor activation and N-type calcium currents in striatal cholinergic interneurons in a mouse model of DYT1 dystonia.Q48436385
The motor phenotype of Parkinson's disease in relation to age at onsetQ50266093
Developmental expression of rat torsinA transcript and protein.Q52088364
Striatal dopamine in early-onset primary torsion dystonia with the DYT1 mutation.Q52278152
Dystonia.Q55042366
Gait dynamics in trisomic mice: quantitative neurological traits of Down syndromeQ80383562
P433issue1
P921main subjectdopamineQ170304
P304page(s)66-78
P577publication date2012-05-31
P1433published inNeurobiology of DiseaseQ15716606
P1476titleFunctional analysis of dopaminergic systems in a DYT1 knock-in mouse model of dystonia
P478volume48

Reverse relations

cites work (P2860)
Q36232197A new knock-in mouse model of l-DOPA-responsive dystonia
Q30441885Abnormal striatal dopaminergic neurotransmission during rest and task production in spasmodic dysphonia.
Q36591812Abnormalities of motor function, transcription and cerebellar structure in mouse models of THAP1 dystonia.
Q35836503Analysis of gait in rats with olivocerebellar lesions and ability of the nicotinic acetylcholine receptor agonist varenicline to attenuate impairments
Q37058173Animal models for dystonia
Q47623854Chemogenetic locus coeruleus activation restores reversal learning in a rat model of Alzheimer's disease
Q90747980Decreased number of striatal cholinergic interneurons and motor deficits in dopamine receptor 2-expressing-cell-specific Dyt1 conditional knockout mice
Q92000933Diverse Mechanisms Lead to Common Dysfunction of Striatal Cholinergic Interneurons in Distinct Genetic Mouse Models of Dystonia
Q48531888Dopamine receptor agonist treatment for idiopathic dystonia: A reappraisal in humans and mice
Q37592345Dystonia as a network disorder: what is the role of the cerebellum?
Q89633692Dystonia: Sparse Synapses for D2 Receptors in Striatum of a DYT1 Knock-out Mouse Model
Q47585471Effects of disulfiram on choice behavior in a rodent gambling task: association with catecholamine levels.
Q42755733Electromyographic evidence in support of a knock-in mouse model of DYT1 Dystonia
Q38124786Emerging common molecular pathways for primary dystonia.
Q37239952Engineering animal models of dystonia
Q33790163Evaluation of AZD1446 as a Therapeutic in DYT1 Dystonia.
Q91676683Freezing of Gait can persist after an acute levodopa challenge in Parkinson's disease
Q48433008Immunochemical localization of vesicular monoamine transporter 2 (VMAT2) in mouse brain.
Q89595744Increased endogenous dopamine prevents myopia in mice
Q33919548Increased vesicular monoamine transporter enhances dopamine release and opposes Parkinson disease-related neurodegeneration in vivo
Q64786603Loss of the dystonia gene Thap1 leads to transcriptional deficits that converge on common pathogenic pathways in dystonic syndromes
Q35049257Minimal Change in the cytoplasmic calcium dynamics in striatal GABAergic neurons of a DYT1 dystonia knock-in mouse model
Q39779374Motor phenotypes and molecular networks associated with germline deficiency of Ciz1.
Q36605114Neuropathology of cervical dystonia
Q48585249Parkinsonism without dopamine neuron degeneration in aged l-dopa-responsive dystonia knockin mice
Q61809637Retracted: Mouse models of GNAO1-associated movement disorder: Allele- and sex-specific differences in phenotypes
Q89675943Short-Wavelength (Violet) Light Protects Mice From Myopia Through Cone Signaling
Q28648007Striatal cholinergic dysfunction as a unifying theme in the pathophysiology of dystonia
Q37383467Striatal dopaminergic dysfunction at rest and during task performance in writer's cramp
Q37424519Subtle microstructural changes of the cerebellum in a knock-in mouse model of DYT1 dystonia
Q36774120Subtle microstructural changes of the striatum in a DYT1 knock-in mouse model of dystonia
Q46481280The Anatomical Basis for Dystonia: The Motor Network Model
Q37070290The focal dystonias: current views and challenges for future research
Q38115272The genetics of dystonia: new twists in an old tale
Q33841496The relationship between the dopaminergic system and depressive symptoms in cervical dystonia
Q36331007The ubiquitin ligase F-box/G-domain protein 1 promotes the degradation of the disease-linked protein torsinA through the ubiquitin-proteasome pathway and macroautophagy.
Q38176494The vesicular monoamine transporter 2: an underexplored pharmacological target
Q37444067Understanding the anatomy of dystonia: determinants of penetrance and phenotype

Search more.